Specialty Rx Is Driving Drug Trend Among CVS Caremark Clients
This article was originally published in The Pink Sheet Daily
Executive Summary
CVS Caremark’s annual Insights report says that while use of generics for small molecule drugs restrained spending growth, an 18.1% surge in spending on specialty medications by its commercial clients pushed the overall drug trend into positive territory in 2012.